<

 
Data updated 2025-06-05 00:05:01
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date10179104.4 (espacenet)  (Federated)  (European Patent Register), 20010803
Patent/reg. no. and dateDK/EP 2348032, 20150715
Publication date20110727
Priority no. and dateGB 0019172, 20000805, GB 0108800, 20010407
EP pub. no. and date EP 2348032 20110727
Effective date
Applicant/ownerGlaxo Group Limited, 980 Great West Road
Brentford, Middlesex TW8 9GS, GB
Applicant ref. no.159058
InventorBiggadike, Keith, GlaxoSmithKline
Gunnels Wood Road
Stevenage, Hertfordshire SG1 2NY, GB,
Coote, Steven, John, GlaxoSmithKline
Gunnells Wood Road
Stevenage, Hertfordshire SG1 2NY, GB,
Nice, Rosalyn, Kay, c/o GlaxoSmithKline,
9890 Great West Road,
Brentford, Middlesex, TW8 9GS, GB
RepresentativeAWA Denmark A/S, Strandgade 56, 1401 København K, DK
Opponent
IPC ClassA61K 31/58 (2006.01) , A61P 5/44 (2006.01) , C07J 31/00 (2006.01) 
Title6.Alpha.,9.alpha.-difluor-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-dien-17-carbothiotinsyre s-fluoromethylester som et anti-inflammatorisk middel.
Int. application no.
Int. publication no.
Related patent (certificate)
StatusUdløbet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact